Background: 38
Results: 48
We mutated mouse CMAH on the most widely human cells transplantation strain NOD/scid-49 IL2Rγ c -/-(NSG) mouse background using the CRISPR/Cas9 system. The new strain provides a 50 better environment for human immune cells. Transplantation of human hematopoietic stem cells 51 leads to broad B cells repertoire, higher sensitivity to HIV-1 infection, and enhanced 52 proliferation of transplanted peripheral blood lymphocytes. The mice showed low effects on the 53 clearance of human immunoglobulins and enhanced transduction efficiency of recombinant 54 adeno-associated viral vector rAAV2/DJ8. 55 All vertebrate cell surfaces display a dense glycan layer often terminated with sialic acids that 68 have multiple functions due to their location and diverse modifications [1] . The major sialic 69 acids in most mammalian tissues are N-acetylneuraminic acid (Neu5Ac) and N-70 glycolylneuraminic acid (Neu5Gc), the latter being derived from Neu5Ac via addition of one 71 oxygen atom by CMP-Neu5Ac hydroxylase (Cmah) . The pattern of proteins glycosylation 72 affects the physiology of the cell, cell-to-cell communication, adhesion, migration, recognition 73 by other cells and antibodies [2] . In infectious diseases, sialylation patterns influence how 74 humans interact with some pathogens or viral vectors: including HIV-1, malaria, influenza, and 75 streptococcus [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . In xenotransplantation and stem cell biology, it is a key factor for graft 76 acceptance and preservation of self-renewing properties [14] . Of the two most common sialic 77 acids forms Neu5Gc is widely expressed on most mammalian tissues but has limited 78 accumulation in human cells [15] . The human deficiency of Neu5Gc is explained by an 79 inactivating mutation in the gene encoding CMP-N-acetylneuraminic acid hydroxylase (CMAH), 80 the rate-limiting enzyme in generating Neu5Gc in cells of other mammals [16] . This deficiency 81 also results in an excess of the precursor Neu5Ac in humans. This mutation appears universal to 82 modern humans and happens to be one of the first known human-great ape genetic differences 83 with an obvious biochemical readout. In particular, it is important for interaction with Sialic 84 acid-binding Ig-like lectins, or Siglecs. Expression of such lectins vary in their specificity for 85 sialic acid-containing ligands and are mainly expressed by cells of the immune system. For 86 example, humans, compared to mice and rats, express a much larger set of CD33rSiglecs [17] . 87
CD33rSiglecs have immune receptor, tyrosine-based inhibitory motifs, and signal negatively 88 [18] . Interaction with Siglec-7 has the potential to also affect monocyte migration and function 89 [19] along with T-cell activation [8, 20, 21] . During B cells activation and germinal center 90 formation (GC), Siglecs are important for appropriate activation of B cells and responses to T-91 cell-dependent and independent antigens [22] . In B-cell antigen receptor (BCR) engagement, 92 interaction of CD22 and Siglec-G has been shown to inhibit the BCR signal [23] . Most 93 importantly, exposure to exogenous Neu5Gc is known to cause rapid phosphorylation of beta-94 catenin in both CMAH-overexpressing cells and bone marrow-derived mesenchymal stem cells, 95 thereby inactivating Wnt/β-catenin signaling and, as a consequence, possibly forcing stem cells 96 to lose pluri-or multipotency [24] . 97
Immunodeficient mice transplanted with human hematopoietic stem/progenitor cells 98 (HSPC) are an established model to study human-specific infections like HIV-1 [25] . However, 99 if a particular sialic acid residue is missing in a donor species (Neu5Gc) and present in the 100 recipient, biologic consequences can be difficult to delineate. Exclusion of mouse Neu5Gc has 101 the potential to improve immune responses to pathogens with non-human patterns of 102 glycosylation like HIV-1 and HCV (hepatitis C virus) and to study the pathogenicity of human-103 like sialylated pathogen surfaces [12, 17, 26, 27] . 104
To distinguish the effect of the expression of CMP-N-acetylneuraminic acid hydroxylase 105 in mice on human HSPC biology, improve the development of a human immune system in mice, 106
and study responses to HIV-1 infection, we generated mutation in exon 6 of the gene on NSG 107 strain using CRISP/Cas9 technology [28] . We compared original NSG and NSG-cmah -/strains 108 for multiple parameters and observed changes in the human lymphocyte phenotype and 109 repertoire. Human lymphocytes generated from HSPC in a human-like sialylation environment 110 exhibit persistence of naïve non-activated T-cell phenotypes and are more sensitive to HIV-1 111 mediated depletion of CD4 + T-cells. Alternatively, mature human lymphocytes derived from 112 human peripheral blood expand more efficiently in the NSG-cmah -/mice with higher levels of 113 activation. 114
This new strain expands the utility of the NSG standard strain used to study human 115 hematopoiesis and immunity and allows comparison of new viral vectors for gene therapy and 116 sensitivity to a wider variety of pathogens. 117
118

Results
119
Generation of NSG-cmah -/mice. 120
To generate a Cmah knockout mouse on NSG background, we designed two single guide RNAs 121 (sgRNAs) targeting exon 6. Schematic of CRISPR targeting are shown in Fig. 1 . Embryo 122 isolation, microinjection, and generation of founder mice were performed as described in Harms 123 et al [28] . Genotyping of pups showed that one founder contained a shorter sized amplicon. 124
Sequencing of the shorter band revealed a deletion of 27 base-pair sequences in the exon. 125
Genotyping of F1 offspring from this founder is shown in Fig. 1b, 1c . 126
127
NSG-cmah -/phenotype 128
To confirm the inactivation of CMAH gene enzymatic activity and the absence of hydrolysis of 129 NSG-cmah -/mice than on the existing strain of immune competent animals. By these three 138 techniques, we confirmed the absence of CMAH gene activity and a human-like sialylation 139 pattern of mouse biomolecules. Breeding for two years did not reveal any differences in fertility, 140 body weight, or life span in comparison to the founder NSG mice. 141
142
Comparison of human immune system development after CD34 + hematopoietic 143 stem/progenitor cell transplantation 144
Another wide application of NSG mice is transplantation of human CD34 + HSPC for the 145 development of human lymphopoiesis [29, 30] . The establishment of human B-cell 146 lymphopoiesis in mouse bone marrow and T-cell lymphocytes in mouse thymus has been well 147 demonstrated [29] . In this model, the expansion of human B cells occurs significantly earlier 148 than CD3 + T cells. We tested whether differences in cell surface glycoproteins sialylation would 149 affect activation of newly generated human lymphocytes. NSG-cmah -/and wild-type (wt) NSG 150 mice were transplanted at birth with the same donor HSPC. At 3 and 6 months post-151 transplantation, the proportion of human T and B cells as well as activation status was 152 determined (Fig. 3) . The following markers were used: CD45RA for naïve CD3 + T cells, CD22 153 for CD19 + B cells. CD22 is a BCR co-receptor that regulates B cell signaling, proliferation, and 154 survival; it is required for T cell-independent antibody responses [31] . The frequency of human 155 T cells in the peripheral blood of 3-month-old mice was higher in NSG wt mice, and the 156 proportion of circulating B cells at the same time was higher in NSG-cmah -/mice. By 6 months 157 of age, there were similar proportions of T and B cells in the peripheral blood ( Fig. 3c ) 158 regardless of sialytion status. In both strains the proportion of CD4 + cells in peripheral blood 159 increased. NSG and NSG-cmah -/mice at this time had similar proportions of naïve 160 CD3 + CD45RA + cells, which declined with time. Human B cells in NSG-cmah -/mice showed a 161 lower number of activated CD19 + CD22 + cells at 3 months of age. The differences in B cell 162 activation (CD22 expression levels) were sustained at 6 months post-engraftment. The 163 proportion of CD19 + IgD + B cells was lower in NSG-cmah -/mice at 3 months and did not decline 164 by 6 months as was found in NSG wt humanized mice. The proportion of CD19 + IgM + IgD + B 165 cells in peripheral blood of both strains declined, and the proportion of CD19 + IgM -IgD + cells 166 [32, 33] increased. We did not observe significant differences in the numbers of CD19 + IgM + IgD -167 mature B cells between strains at 6 months (5.9 ± 0.9% and 7.7 ± 1.3% NSG-cmah -/and NSG, 168 respectively). The low levels of CD19 + IgG + (0.7 -3.8%, not shown) cells were found in both 169 strains. The levels of IgM at 6 months of age varied from 1-350 μg/ml ( Fig. 3c) and only low 170 levels of IgG (1 -50 μg/ml, not shown) were present in both strains at 6 months of age. 171 172
Analysis of T and B cell repertoires in NSG-cmah and wild type NSG mice 173
To characterize the global B and T cells receptor repertoires, we selected non-fractionated bone 174 marrow cells suspension and spleen tissue samples. Human-specific primers were selected for 175 analysis of human cells according to Adaptive Biotechnologies® (Seattle, WA, USA) 176 technology [34] . We compared the repertoire profiles of bone marrow and spleen within one 177 mouse and between NSG-cmah-/-and wt NSG mice. The generation of mature human 178 lymphocytes requires a complex selection process in bone marrow (B cells) and thymus (T cells) 179 and are highly dependent on the microenvironment. Glycosylation of stromal mouse counter-180 receptors is important for pre-B cells signaling and proliferation [35] and retention in bone 181 marrow for B cells [36] . Maturation and activation of human B and T cells in mouse primary 182 (bone marrow and thymus) and secondary lymphoid organs (spleen, lymph nodes) will likely 183 affect B and T cell receptors repertoire and development [37] . Using the same donor of HSPC, 184 we compared the B and T cell receptors repertoires in the new and existing NSG strain at 8 185 months of age. Spleen tissue and bone marrow pelleted cells were used for genomic DNA 186 (gDNA) extraction and immunosequencing provided by Adaptive Biotechnologies®. Collected 187 data were analyzed using immunoSEQ Analyzer (https://www.adaptivebiotech.com/). We used 188 the common indexes to determine diversity of repertoires based on DNA sequences of the 189 rearranged V-D-J gene segments encoding the third complementarity-determining region 190 (CDR3) of IgH loci and T cell receptor beta chain (TCRβ) in a given sample, the length of 191 CDR3, and usage of IgH and TCRβ genes ( Fig. 4 and additional files 1-5 Fig. S1 -S5) . 192
Gaussian-like distribution patterns of IgH CDR3 length in NSG-cmah -/mice were 193 similar to wt NSG (Fig. 4a, 4b) mice. In contrast, the frequency of clonal B-cell expansion was 194 more common in the wt NSG mice, and the difference was close to statistical significance. A 195 similar size distribution pattern of IgH CDR3 length was observed in bone marrow samples 196 evaluated for five NSG-cmah -/mice. The NSG animals analyzed also had significant variability 197 (Additional file 1, Fig. S1b , two animals). The variability in NSG mice was also reflected by 198 variable total number of templates (Additional file, Fig. S1e ). We observed lower diversity of B 199 cell repertoires in NSG mice compared to NSG-cmah -/strain according to higher clonality of 200
IgH genes in bone marrow and spleen ( Fig. 4c and additional file 1, Fig. S1c ). The average IgH 201 CDR3 length naturally generated by the rearrangement machinery was found to be reduced 202 during B cell development and we observed slight shift to the left of CDR3 length in 4 of 5 203 analyzed NSG-cmah -/mice by comparing bone marrow and spleen compartments (Additional 204 file 2, Fig. S2 ). The use of IgH genes families were similar in spleen and bone marrow 205 (Additional file 3, Fig. S3C ) and correspond to the known human peripheral blood B cell data 206 [38, 39] . We observed similar changes in IgH D and J gene family usage between bone marrow 207 (pre-and immature B cells) and spleen compartment with mature B cells (Additional file 3, Fig.  208 S3C). The clonality of IgH gene loci were two folds higher in spleen compared to bone marrow, 209 and in cmah -/mice reached statistical significance ( Fig. 4d) . 210
We did not observe significant differences in TCRβ chain gene usage (Additional file 4, 211 clonality was lower in spleen compared to bone marrow in both strains, but these changes did not 213 reach statistical significance (Additional file 5, Fig. S5b ). The richness of repertoire was higher 214 in spleen tissues compared to bone marrow samples in both strains (Fig. 5d ). We did not observe 215 statistically significant differences in TCRβ CDR3 length (Additional file 5, Fig. S5a, 5b) in 216 spleen and bone marrow (not shown). Overall CDR3 length (nucleotides) was shorter in T cells 217 compared to B cells. We did not find statistically significant differences in samples clonality and 218 noted higher TCRβ richness in spleen compared to bone marrow as total number of TCRβ chain 219 gene templates. Additionally, we observed better Pielou's evenness of TCRβ in NSG cmah -/-220 mice and overall increased evenness in spleen compared to bone marrow compartment 221 (Additional file 5, Fig. S5c, 5d , and 5e). 222 223
Comparison of human immune system responses to HIV-1 infection in NSG-cmah -/and wt 224
NSG mice 225 NSG mice, humanized by human hematopoietic stem cell transplantation, are a proven model to 226 study the pathogenesis of HIV-1 infection [38] . We evaluated the effects of human-like 227 sialylation of mouse tissues on the sensitivity of human cells to HIV-1. Two groups of mice with 228 similar levels of reconstitution of circulating human CD45 + cells in peripheral blood were 229 infected with the same dose of HIV-1 ADA intraperitoneally at the age of 30-32 weeks when the 230 majority of peripheral human cells were CD3 + CD45RA +-T cells. Four weeks post-infection, 231 peripheral blood, spleen, and bone marrow samples were analyzed ( Fig. 5 and 6 , Additional files 232 6 and 7, Fig. S6, S7 ). We observed a significant reduction in human T cells in all three 233 compartments in NSG-cmah -/mice including both CD3 + and CD3 + CD4 + T-cells. The total 234 number of CD4 + CD45RO + cells and among this antigen-stimulated cells proportion of 235 CD4 + CD45RO + CD62L -CCR7effector memory cells, the most sensitive to HIV-1 depletion, 236 decline in cmah -/mice compared to unaffected. The result was an increased frequency of central 237 memory T cells CD4 + CD45RO + CD62L + CCR7 + in the peripheral blood and spleen of HIV-1 238 infected mice. This effect was not observed in NSG mice peripheral blood and spleen 239 compartment. We found a higher HIV-1 viral load (VL) in the peripheral blood of NSG-cmah -/-240 mice at 4 weeks post-infection. In both strains, VL persisted at high levels for up to 9 weeks 241 post-infection. As T cells decreased, we observed an increased frequency of B cells in all three 242 compartments (blood, spleen, bone marrow). We also noted an increased proportion of human 243 CD1c + cells in spleen of infected NSG-cmah -/mice compared to wt NSG. Corresponding 244 increases in myeloblasts (CD34 + CD117 + ), promonocytes (CD4 dim CD14 neg or dim ), and mature 245 monocytes (CD4 dim CD14 bright ) in bone marrow of HIV-1 infected NSG-cmah -/mice were 246 observed ( Fig. 6c ). We did not observe any differences in natural killer (NK) and NKT cells 247 subpopulations (not shown) between the two strains. We also did not find differences in the 248 levels of immune globulins and circulating HIV-1 specific binding antibodies. At nine weeks 249 post-infection, in peripheral blood of HIV-1 infected NSG-cmah -/mice, the decreased 250 proportion of CD3 + cells and specifically CD4 + CD45RO + effector memory cells with increased 251 number of monocytes CD14 + were found (Additional file 7, Fig. S7 ). 252
Effects of NSG-cmah -/phenotype on transplanted human peripheral blood mononuclear 254 cells behavior 255
NSG mice are widely used for the transplantation of human peripheral blood immune cells 256 (PBMC) [39] . We considered that the absence of Neu5Gc and human-like sialylation of 257 glycoproteins could change the behavior of mature human immune cells derived from the adult 258 donor. PBMC isolated from one donor were transplanted into the NSG and NSG-cmah -/mice 259 intraperitoneally. Starting from day 7 post-transplantation, mouse peripheral blood was collected 260 and stained for the presence of human immune cells ( Fig. 7) . Human T lymphocytes were the 261 major population with low absolute number of B cells and monocytes in peripheral blood. The 262 expansion of human cells in NSG-cmah -/mice significantly (~2 -3.5 times) exceeded that seen 263 in the NSG mice, and the absolute count of human CD45 + cells (mean ± SEM) were 16 ± 2 vs 9 264 ± 1 cells/μl at day 7, 513 ± 135 vs 146 ± 58 cells/μl at day 14, 474 ± 130 vs 168 ± 118 at day 21 265 (P < 0.05) (Fig. 7b) . The proportion of human cells in spleen were similar at the end-point of 266 observation ( Fig. 7c) . Human T-cells in the mouse environment became activated and switched 267 expression of CD45RA (naïve) to CD45RO (effector-memory). The activation of CD4 + cells in 268
Cmah -/mice significantly exceeded the CD45RO to CD45RA switch in wt NSG mice. To a 269 lower extent, the same was observed within CD8 + T-cells ( Fig. 7d) . L-selectin (CD62L) is an 270 adhesion molecule that recognizes sialylated carbohydrate groups, mediates the first steps of 271 leukocyte homing to peripheral lymph nodes, and is programmed for recirculation through 272 lymphoid organs, thus crucially controlling the initiation and maintenance of immune responses 273 to pathogens [40] . CD62L + T-cells also were generated at higher frequency in Cmah -/mice, 274
including the splenic population of CD4 + CD45RO + CD62L + (Fig, 7e) . Overall, for this particular 275 donor, engraftment and expansion of mature human peripheral blood lymphocytes were more 276 pronounced in the NSG-cmah -/mouse strain. 277
278
Host glycoproteins sialylation pattern affects the clearance of HIV-1 virus, half-life of 279 infused human IgG and rAAV2/DJ8 biodistribution 280
There is evidence that evolutionary loss via mutation of the CMAH genes changed the sensitivity 281 of humans to viral and bacterial pathogens [41, 42] . We investigated the life-span of HIV-1 virus 282 in the two mouse strains since the mouse is not a normal permissive host. We tested the 283 concentration and time of HIV-1 VL in the peripheral blood of the non-humanized mouse as a 284 parameter that potentially could influence viral pathogenicity. On the first and second day after 285 intraperitoneally injection of 0.3 ml of HIV-1 ADA viral stock, the detected copy numbers of HIV 286 RNA were lower by ~0.3 log 10 in NSG-cmah -/mice compared to NSG [4.98 ± 0.1 and 4.1. ± 287 0.08 compared to 5.25. ± 0.06 and 4.4 ± 0.05 log 10 , respectively (P < 0.05, Fig. 8a) ]. 288
The clearance of sialylated glycoproteins going through the multiple types of receptors 289 and changes of mouse sialylation could affect interaction with human immune globulins. We 290 compared the time of circulation of human IgG in NSG-cmah -/and wt mice ( Fig. 8b ). We were 291 not able to determine the first minutes of injected IgG dose clearance, but overall clearance of 292 human IgG was nearly identical in the two strains of mice. A slightly higher concentration 293 remained in NSG-cmah -/mice compared to NSG at the end of observation (1.1 ± 0.04 and 0.9 ± 294 0.03 μg/ml for NSG-cmah -/and wt mice, respectively) (P < 0.05). 295
Biodistribution and expression levels of recombinant adeno-associated virus (rAAV) 296 vector delivered genes could be affected by sialylation of host receptors [5, 10, 43] . We 297 compared the luciferase expression delivered by rAAV2/DJ8. We were not able to detect 298 statistically significant differences in luminescence in liver and spleen between the two strains at 299 7, 14, and 21 days post-inoculation (data not shown). However, at 32 days the expression of 300 luciferase RNA was significantly higher in the spleen and brain of NSG-cmah -/as determined by 301 ddPCR (Fig. 8c) . It was higher by 0.60 log 10 copies in spleen (4.72 ± 0.12 vs 4.12. ± 0.07 log 10 ) 302 and 0.54 log 10 in brain (1.40 ± 0.11 vs 0.85. ± 0.12 log 10 ) of cmah -/mice compared to NSG (P < 303 0.05). 304 305 Discussion 306
We created NSG-cmah -/mice with the intent to use this strain for different aspects of biomedical 307 research. As initial phenotypic characterization, we compared several parameters involved in 308 human immune system development in NSG-cmah -/to the parent NSG strain. Glycoproteins-309 lectin interactions (for example, hematopoetic cells surface glycoporteins -bone marrow stromal 310 cell lectins/selectins) are an important mechanism of human B-cell selection. The NSG mouse 311 environment that contained Neu5Gc (non-human type of sialylation) exhibited a higher 312 frequency of clonal B-cell outgrowth that may represent responses against the Neu5Gc moiety. 313
In the absence of Neu5Gc, human B cells appear to remain less activated. This finding indicates 314 that non-human sialylation has a negative effect on human B cell development, and the NSG-315 cmah -/strain provides a more supportive environment with good repertoire development and less 316 clonal outgrowth [44] . The observations of lower IgD + and CD22 + human B cells and sustained 317 naïve CD45RA + CD3 + cells in the NSG-cmah -/strain also support this conclusion. 318
We observed better bone marrow B-cell precursor engraftment in control NSG mice 319 compared to NSG-cmah -/-, and better bone marrow T-cell engraftment in NSG-cmah -/-. The HIV-320 1 infected NSG-cmah -/mice showed a significant reduction in bone marrow T-cells and a 321 subsequent increase in bone marrow B-cell precursor engraftment. These findings may indicate 322 T-cell suppression of B-cell engraftment is occurring in this mouse strain but will require further 323 study to confirm. In contrast, the NSG strain showed similar levels of bone marrow T-cell and B-324 cell engraftment regardless of infection with HIV-1. 325
The T cell TCRβ chain repertoires in NSG-cmah -/and wt NSG mice were not different 326 in clonality metrics and remain polyclonal in bone marrow and spleen. However, compared to wt 327 NSG mice, NSG-cmah -/exhibited better evenness of repertoire between spleen and bone 328 marrow. We did not observe statistically significant differences in clonal T-cell expansion based 329 on TCRβ CDR3 length frequency in bone marrow versus spleen. This was previously reported 330 for NOD/scid mice transplanted with cord blood derived hematopoietic CD34 + stem cells [45] . 331
In the studies presented here, we are not showing effects of vaccination with the 332 childhood vaccines DTaP, HiB, and MMRII, which were tested in comparison on both strains of 333 humanized mice at 6 months of age. Only a few animals developed antigen-specific IgM. The 334 inability of CD34-NSG humanized mice to efficiently respond to vaccination is related to 335 multiple deficiencies recognized in the humanized animals. This includes the absence of 336 supportive cytokines, human follicular dendritic cells responsible for accumulation of antigen 337 and stimulation of germinal center B-cells, deficiency of follicular helper cells involved in T-cell 338 dependent immune responses, deficiency of complement, and others (reviewed in [46] ). Several 339 approaches to improve human adaptive immune responses were explored by elimination of 340 mouse tissue histocompatibility antigens and introducing human MHC class I and II, cytokines 341 and co-transplantation of bone, spleen, liver, and thymus. These approaches improved adaptive 342 responses to varying degrees. It is possible that the introduction of these additional factors on the 343 NSG-cmah -/background will further optimize the function of the human immune system and 344 development of adaptive immune responses. 345
In addition to the comparison of human immune system cell development and phenotype, 346
we assessed the behavior of human mature peripheral blood mononuclear cells in their ability to 347 colonize mouse spleen and peripheral blood. In contrast to lymphocytes generated from human 348 stem cells transplanted into NSG-cmah -/mice, which showed reduced levels of activation, 349 transplanted mature lymphocytes very quickly expand and lose the naïve CD45RA + phenotype. 350
This could be attributed to the selection of human T cells in mouse thymus and reduced 351 responsiveness to the mouse MHC (major histocompatibility) antigens. 352
Sialic acid on cellular membrane molecules has been identified as an attachment receptor 353
for several pathogens and toxins. The composition could influence the viral capture by different 354 cell types and trans-infection [47] . We observed increased HIV-1 mediated depletion of human 355 CD4 + T-cells in the NSG-cmah -/strain of mice compared to the parental NSG. We also found a 356 reduction of circulating HIV-1 RNA in non-engrafted NSG-cmah -/mice suggesting the viral 357 particles may be more efficiently absorbed by cells with human-like sialylation patterns. We 358 previously showed that mice transplanted with human hepatocytes also had enhanced clearance 359 of virus from the circulation [48] . The increased pathogenicity of HIV-1 in NSG-cmah -/mice 360 may be related to both the properties of human cells raised in the more human-like modified 361 mouse environment as well as interaction of virus with the modified mouse stroma. IgG as previously analyzed [52] . Our observation of slower clearance of human IgG injected 371 intravenously in NSG-cmah -/mice suggests the model may be useful for evaluation of the 372 therapeutic efficacy of human antibodies. Another miscellaneous application of NSG-cmah -/-373 mice could be testing of the transduction efficacy of viral vectors as well as viruses [53] . We 374 used a common vector of rAAV serotype 2 with luciferase and expected to see the differences of 375 transduction efficacy between wt NSG and NSG-cmah -/mice. We found the expression of 376 luciferase was not different in liver (the major affected organ), but we did observe differences in 377 less commonly affected organs -such as spleen and brain. These findings suggest that 378 endothelial and splenic hematopoietic cells with human-like sialylation profiles could be more 379 sensitive to viral infection. 380 381
Conclusions 382
Humanized mice are widely used to study the human immune system responses to pathogens and 383 therapeutics. However, mouse specific glycosylation affects the development of the human 384 immune system and responses to various agents -such as viruses or biological, human-specific 385 products like antibodies. We demonstrated that human-specific sialylation established by 386 mutation of the CMAH gene supports naïve B and T cell generation with polyclonal receptors 387 repertoires. In contrast to NSG wild type mouse sialylation background, we found the NSG- Generation of B6.129X1-Cmah tm1Avrk /J referred hereafter as C57Bl/6-Cmah -/was 399 described previously [54] . In this mouse, exon 6 was deleted by targeting a cassette containing 400
LoxP flanked exon 6 with a neomycin cassette into 129/SvJ derived ES cells, followed by 401 removal of the exon and the neomycin cassette through Cre enzyme and injection of deleted 402 clone into blastcysts to generate chimera. The mice line was backcrossed to C57BL6/J strain for 403 10 generations. 404 405 CRISPR reagents, mice generation, and genotyping 406
We deleted exon 6 using CRISPR approach in NSG strain background. Two guide RNAs were 407 identified to target exon 6 (Cmah gRNA 1 CTTTGTGCATTTAACGGACCTGG and Cmah 408 gRNA 2 TGAAATATATCAACCCTCCAGGG). The sgRNAs were transcribed from DNA 409 templates generated by annealing two primers using the HiScribe™ T7 Quick High Yield RNA 410 Synthesis Kit (New England Biolabs, Ipswich, MA) following manufacturer's instructions. Cas9 411 mRNA was prepared using the pBGK plasmid as described in [28] . Injection mixture was 412 prepared by dilution of the components into injection buffer (5 mM Tris, 0.1 mM EDTA, pH 7.5) 413 to obtain the following concentrations: 10 ng/μl Cas9 mRNA, 10 ng/μl Cmah Left Guide and 414
Right Guide RNA. Female NSG mice 3-4 weeks of age (JAX Laboratories, Bar Harbor, ME, 415 USA) were superovulated by intraperitoneal injection with 2.5IU pregnant mare serum 416 gonadotropin (National Hormone & Peptide Program, NIDDK), followed 48 hours later by 417 injection of 2.5 IU human chorionic gonadotropin (hCG, National Hormone & Peptide Program, 418 NIDDK) . Mouse zygotes were obtained by mating NSG stud males with superovulated NSG 419 females. The animals were sacrificed 14 hours following hcG administration, and oviducts were 420 collected to isolate fertilized embryos. Injection mixture was introduced into the pronuclei and 421 cytoplasm of fertilized NSG embryos by microinjection using a continuous flow injection mode. 422
Surviving embryos were surgically implanted into the oviducts of pseudopregnant CD-1 423 recipient females. Genomic DNAs were extracted from tail biopsies and genotyping PCRs were 424 performed as previously reported [28] . Cmah Forward TCCCAGACCAGGAGGAGTTA and 425
Cmah Reverse TCCACTCCGAGTTTCAGATCA primers were used for screening by PCR. The 426 expected amplicon sizes were 455 bases and 428 bases respectively for wild type and mutant 427 mice. The PCR products were column purified and were sequenced using the primers used for 428 PCR amplification. human PBMC intraperitoneally (20 × 10 6 cells/mouse). Blood samples were collected by facial 465 vein bleeding for immunophenotyping at variable intervals (7, 14, 24, 31 days). Five-week post-466 injection, mice were sacrificed; blood, liver and spleen tissues were collected for 467 immunophenotyping and immunohistochemistry. Briefly, 50 µL of whole blood was stained in 468 EDTA-coated tubes with two different monoclonal antibody panels (Table 1) Immunophenotyping was performed to determine the absolute count and frequency of blood 473 cells: leukocytes (CD45, BD Biosciences, Cat. #555482); CD3 (#557943); CD4 (#560650); CD8 474 (#562428); CD19 (#562653) and CD14 (eBioscience, San Diego, CA, Cat. #17-0149-42) for 475 blood and spleen, respectively. The gating strategy for identification of cell subsets is presented 476 in Figure 1A . Presence of activation markers CD45RA/CD45RO (BD Biosciences, #560674; 477 #563215) and CD62L (#555544) were also checked for CD4 + and CD8 + T cells subpopulations, 478 CD22 on B cells (#563940) in blood and spleen as absolute count and frequency of parent, 479 respectively. After staining of cells, red blood cells were lysed with FACS Lysing solution (BD 480 Biosciences), and cells were washed with PBS and resuspended in 1% paraformaldehyde. For 481 absolute counting of the blood samples, CountBrightTM absolute counting beads (Invitrogen, 482 Carlsbad, CA, USA; catalog C36950) were added to each sample before acquisition. Acquisition 483 of stained cells was performed on BD LSR II (BD Biosciences) using acquisition software FACS 484 Diva (BD Biosciences); and data were analyzed using FLOWJO, analysis software (Tree Star). anti-CD117 (clone 95C3) and V500c-conjugated CD45 (clone 2D1) and the BCL tube 528 consisting of FITC conjugated anti-kappa (clone TB28-2), PE conjugated anti-lambda (clone 1-529 155-2), PE-Cy7 conjugated anti-CD10, PerCP-Cy5.5 conjugated anti-CD19 (clone SJ25C1), 530 APC-H7 conjugated anti-CD20 (clone L27), APC conjugated anti-CD24 (clone 2G5), V450 531 conjugated anti-CD38 (clone HB7) and V500c-conjugated CD45 (clone 2D1). All antibodies 532 were obtained from BD Biosciences (Franklin Lakes, NJ, USA) except CD24 and CD117, which 533 were obtained from Beckman Coulter (Brea, CA, USA). 534
After incubation, the cells were washed twice with 1 mL PBS and were resuspended in 535 500 uL PBS containing stabilizer (BD Biosciences) to fix the cells. Fifty thousand to 100,000 536 cell events were collected for each sample on a Becton Dickinson FACS Canto II (Franklin 537
Lakes, NJ, USA). Analysis of the FCS files was performed using Kaluza 1.3 analysis software 538 (Beckman Coulter). 539
Gating schemes for the bone marrow analysis are shown in the additional file 6 Fig. S6 . 540
For all bone marrow cell populations characterized, total cell events were derived based 541 on gating and logical antigen (Boolean) profiles. Population frequencies were then derived by 542 dividing the specific cell population events by the total human cell events after CD45 and singlet 543 gating. 544
545
HIV-1 viral clearance 546
Viral clearance naïve non-humanized animals were injected with HIV-1 stock 3×10 3 547 TCID 50 /mouse), and blood was collected on days 1, 2, 5, and 7 post inoculation. Number of viral 548 RNA copies were determined as described above. were loaded into a QX200 droplet reader (Bio-Rad). Discrimination between negative droplets 572 (no luciferase copies) and positives (with luciferase copies) was used to estimate concentration 573 of targets (luciferase copies/ul) using QuantaSoft analysis software (Bio-Rad). The resulted 574 copies were normalized to input RNA and represented as luciferase copies in log scale. 575
Human IgG clearance 576
We compared the circulation time of human IgG (IVIG, PRIVIGEN, CSL Behring LLC). NSG-577 cmah -/and control mice were injected with 100 μl of 10% IVIG in saline. Blood samples were 578 collected at 30 minutes after IVIG injection as point day 0. The actual concentration of human 579 IgG in peripheral blood was measured at days 1, 2, 3, 6, 7, and 14. Plasma human IgG 2018, 7(2) . 784 a Individual IgH genes families usage in NSG-cmah -/and b NSG wt mice represent the 817 summary of productive rearrangement frequency in spleen tissue samples. Similar profiles were 818 found in bone marrow (not shown). c The frequency of V, D and J genes family usage in bone 819 marrow and spleen tissue are highly similar in both strains as expected. As shown, there are no 820 significant differences between NSG and NSG-cmah -/mice in overall IgH gene family usage. In 821 both strains, a significant reduction in the frequency of IGHD02 usage was apparent in splenic 822 B-cells compared to bone marrow. Mild increased frequencies in IGHD01, IGD06, and IGD07 823 usage was also noted in NSG-cmah -/splenic tissue. In NSG wt mice, only IGD03 usage was 824 increased in splenic B-cells compared to bone marrow. For J family usage, an increase in 825 IGHJ03 frequency was found in NSG-cmah -/splenic B-cells with a reduction of IGHJ05 and 826 which was statistically significant by one-way paired t-test (P = 0.0381) for NSG-cmah -/mice. 839
Five animals per strain were used. d The richness of TCRβ chain gene repertoire in both strains 840 was higher in spleen compared to bone marrow (*P < 0.05), while the number of total 841 TCRβ chain gene templates was not statistically different between strains (not shown). e The 842
Pielou' evenness of repertoires in the bone marrow and splenic compartments was not 843 significantly different in both strains; however, the evenness was higher in the spleens of NSG-844 cmah -/mice (one tail paired t-test, P = 0.0312). Red dashed line highlights higher evenness of 845 TCRβ in NSG-cmah -/strain compared to wild type NSG by one-tail Mann Whitney test (P = 846 0.0446). 847 848 Additional file 6. Fig. S6 . Humanized bone marrow gating strategies. 849
For all tubes, the human cells were isolated based on human CD45 expression. The CD45-850 positive cells were secondarily isolated using a singlet gate (forward angle peak height vs. 851 forward angle area) to eliminate cell doublets and triplets. The percentage of lymphocytes was 852 enumerated based on two CD45 by light scatter displays so that cells had to be present in both 853 gates to be considered lymphocytes. T-cells, NK-cells, and monocytes were enumerated using a 854 T-cell/NK-cell cocktail containing CD3, CD4, CD7, CD8, CD14, CD16, and CD56. T-cells were 855 identified as CD3-positive, low side light scatter events. The CD3-positive T-cells were further 856 characterized for CD4 and CD8 expression to enumerate the helper and cytotoxic T-cell subsets. 857 NK-cells were isolated using a low side light scatter (SS) gate on the CD45 by side light scatter 858 histogram. The low SS cells were characterized for CD56 and CD16 expression to enumerate the 859 two NK-cell subsets (not shown here). Monocytes were isolated using a Boolean logic gate as 860 CD4 dim and not CD3-positive cells. Promonocytes and mature monocytes were further identified 861 based on CD14 expression density. CD19-positive, CD10-positive and CD20 positive B-cells 862 were enumerated using a B-cell specific cocktail containing kappa, lambda, CD10, CD19, CD20, 863 CD24 and CD38. CD19-positive, low SS cells were gated to enumerate total B-cells and 864 precursors. The CD19-positive B-cells were further characterized for expression of CD10 to 865 identify the B-cell precursors and CD20 to identify transitional to mature B-cells. Myeloblasts, 866 proB-cells, preB-cells, mast cells, and granulocytes were enumerated using a myeloid cell 867 cocktail containing HLA-DR, CD10, CD13, CD24, CD33, CD34 and CD117. CD34-positive 868 events were gated on a CD34 by SS histogram and were further characterized as myeloblasts or 869 pro B-cells based on the CD45 by SS profile. Total B-cell precursors were isolated based on 870 HLA-DR, CD10, and CD24 co-expression. PreB-cells were calculated using Boolean logic as 871 total B-cell precursors and not proB-cells. Mast cells were enumerated as CD117 bright events on a 872 CD34 by CD117 display. Finally, the granulocytes were estimated based on a CD45 by high SS 873
gate that excluded the CD117 Whitney test (#). P ≤ 0.05 were considered significant. Viral load at 4 weeks post infection was 952 compared with unpaired t test with Welch's correction. In comparison to NSG mice, NSG-cmah -/-953 mice showed a higher sensitivity to HIV-1 infection with increased viral load at 4 weeks post 954 infection and a significant decrease in numbers of CD4 + T cells including effector 955 CD4 + CD45RO + CD62L -CCCR7cells post-infection. Profiling results of animals euthanized at 9 956 weeks post-infection are shown in Supplemental Material (Fig. S7) . Wallis test and Dunn's multiple comparisons tests (*) and Mann-Whitney test (#). P ≤ 0.05 were 967 considered significant. The gating strategies are shown in Supplemental Material (Fig. S6) . 100 μl of a 10% human IgG (10 mg/mouse) were 10.6 ± 1.2 and 11.0 ± 0.9 μg/ml for NSG-988 cmah -/and wild type mice, respectively. Five to three blood samples were collected for days 1 -989 14 time points, mean and SEM are shown. End-point IgG concentrations in peripheral blood 990 were 1.1 ± 0.04 and 0.9 ± 0.03 μg/ml for NSG-cmah -/and wild type mice, respectively. c 991 Luciferase RNA expression at 32 days post intravenous injection in liver, spleen, and brain. (#) P 992 ≤ 0.05 were considered significant by one-tail Mann-Whitney test. 993
